Medtronic plc Stock News

In the closing of the recent trading day, Medtronic (MDT) stood at $86.18, denoting a -1.12% change from the preceding trading day.

Investing in dividend stocks is generally reserved for those who prefer steady returns and low volatility over the thrill of rapid potential gains. Investors saw tech stocks explode in 2023 as art

DUBLIN , Feb. 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 202

Medtronic (MDT) concluded the recent trading session at $86.75, signifying a -1% move from its prior day's close.

Medtronic expects its business to generate around 5% organic growth for fiscal 2024. A return to normalcy in the healthcare industry should benefit the medical device company.

Today's dividend stocks are increasingly popular in a wild reversal as top tech stocks take center stage and push market indices back to all-time highs. But that presents a prime opportunity for incom

The latest trading day saw Medtronic (MDT) settling at $86.97, representing a -0.54% change from its previous close.

My Best Dividend Aristocrats For February 2024

Given its better prospects, we believe Medtronic stock (NYSE: MDT) is a better pick than its peer, Abbott stock (NYSE: ABT). Abbott trades at a higher valuation multiple of 4.9x revenues vs.

Medtronic's global medical device business has supported annual dividend raises since 1978, and it's well positioned for more growth. AbbVie's lead drug fell off a patent cliff last year, but soaring

2024 could easily turn into the year that value stocks come out on top. Though “official” numbers say differently, there's a clear sense of unease as tech-heavy indices soar to all-time highs desp

Medtronic (MDT) concluded the recent trading session at $84.72, signifying a -1.88% move from its prior day's close.

Aging stocks (or longevity stocks) are drawing attention from investors for obvious reasons. The Baby Boomer generation is now almost fully retired, and Gen X is right on its heels.

Blue-chip healthcare stocks tend to be among the top portfolio picks for long-term investors today. Though their blue-chip status implies maturity, which they have, it also implies that the companies

Medtronic is implementing important changes to its business. The company is also investing in high-growth areas.